Viral infections activate types I and III interferon genes through a common mechanism
- PMID: 17204473
- DOI: 10.1074/jbc.M608618200
Viral infections activate types I and III interferon genes through a common mechanism
Abstract
Viral infections trigger innate immune responses, including the production of type I interferons (IFN-alpha and -beta) and other proinflammatory cytokines. Novel antiviral cytokines IFN-lambda1, IFN-lambda2, and IFN-lambda3 are classified as type III IFNs and have evolved independently of type I IFNs. Type III IFN genes are regulated at the level of transcription and induced by viral infection. Although the regulatory mechanism of type I IFNs is well elucidated, the expression mechanism of IFN-lambdas is not well understood. Here, we analyzed the mechanism by which IFN-lambda gene expression is induced by viral infections. Loss- and gain-of-function experiments revealed the involvement of RIG-I (retinoic acid-inducible gene I), IPS-1, TBK1, and interferon regulatory factor-3, key regulators of the virus-induced activation of type I IFN genes. Consistent with this, a search for the cis-regulatory element of the human ifnlambda1 revealed a cluster of interferon regulatory factor-binding sites and a NF-kappaB-binding site. Functional analysis demonstrated that all of these sites are essential for gene activation by the virus. These results strongly suggest that types I and III IFN genes are regulated by a common mechanism.
Similar articles
-
IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.J Immunol. 2007 Sep 15;179(6):3434-42. doi: 10.4049/jimmunol.179.6.3434. J Immunol. 2007. PMID: 17785777
-
Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.J Virol. 2020 Jun 16;94(13):e00099-20. doi: 10.1128/JVI.00099-20. Print 2020 Jun 16. J Virol. 2020. PMID: 32295922 Free PMC article.
-
Hepatitis C virus NS3/4A protease blocks IL-28 production.Eur J Immunol. 2012 Sep;42(9):2374-82. doi: 10.1002/eji.201242388. Eur J Immunol. 2012. PMID: 22685015
-
[Role of IPS-1 in type I IFN induction].Nihon Rinsho. 2006 Jul;64(7):1231-5. Nihon Rinsho. 2006. PMID: 16841392 Review. Japanese.
-
Mechanisms of type III interferon expression.J Interferon Cytokine Res. 2010 Aug;30(8):573-8. doi: 10.1089/jir.2010.0063. J Interferon Cytokine Res. 2010. PMID: 20645874 Review.
Cited by
-
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.Viruses. 2022 Sep 8;14(9):1991. doi: 10.3390/v14091991. Viruses. 2022. PMID: 36146796 Free PMC article. Review.
-
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma.Front Immunol. 2021 Nov 10;12:731807. doi: 10.3389/fimmu.2021.731807. eCollection 2021. Front Immunol. 2021. PMID: 34899691 Free PMC article. Review.
-
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.PLoS Pathog. 2008 Mar 14;4(3):e1000017. doi: 10.1371/journal.ppat.1000017. PLoS Pathog. 2008. PMID: 18369468 Free PMC article.
-
Tick-Borne Viruses and Biological Processes at the Tick-Host-Virus Interface.Front Cell Infect Microbiol. 2017 Jul 26;7:339. doi: 10.3389/fcimb.2017.00339. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28798904 Free PMC article. Review.
-
An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation.EBioMedicine. 2023 Aug;94:104694. doi: 10.1016/j.ebiom.2023.104694. Epub 2023 Jul 11. EBioMedicine. 2023. PMID: 37442062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous